-
公开(公告)号:US20050014686A1
公开(公告)日:2005-01-20
申请号:US10343288
申请日:2001-07-30
申请人: Rainer Albert , Wlifried Bauer , David Bodmer , Christian Bruns , Ivo Felner , Heribert Hellstern , Ian Lewis , Mark Meissenbach , Gisbert Weckbecker , Bernhard Wietfeld
发明人: Rainer Albert , Wlifried Bauer , David Bodmer , Christian Bruns , Ivo Felner , Heribert Hellstern , Ian Lewis , Mark Meissenbach , Gisbert Weckbecker , Bernhard Wietfeld
IPC分类号: A61K45/00 , A61K38/00 , A61K38/04 , A61K38/28 , A61K49/00 , A61K49/04 , A61K51/00 , A61P1/00 , A61P1/04 , A61P1/12 , A61P1/18 , A61P5/10 , A61P5/48 , A61P7/02 , A61P9/00 , A61P9/08 , A61P9/10 , A61P13/12 , A61P27/02 , A61P29/00 , A61P31/18 , A61P35/00 , C07K1/06 , C07K7/64 , C07K14/655 , A61K38/12
CPC分类号: C07K7/64 , A61K38/00 , C07K14/655 , Y02P20/55
摘要: The invention provides cyclo[{4-(NH2—C2H4—NH—CO—O—)Pro}-Phg-DTrp-Lys-Tyr(4-Benzyl)-Phe], optionally in protected form, or a pharmaceutically acceptable salt or complex thereof, which has interesting pharmaceutical properties.
摘要翻译: 本发明提供任选以保护形式的环[{4-(NH 2 -C 2 H 4 -NH-CO-O-)Pro} -Phg-DTrp-Lys-Tyr(4-苄基)-Phe]或其药学上可接受的盐或 其复合物,其具有有趣的药物性质。
-
公开(公告)号:US07939625B2
公开(公告)日:2011-05-10
申请号:US12265135
申请日:2008-11-05
申请人: Rainer Albert , Wilfried Bauer , David Bodmer , Christian Bruns , Ivo Felner , Heribert Hellstern , Ian Lewis , Mark Meisenbach , Gisbert Weckbecker , Bernhard Wietfeld
发明人: Rainer Albert , Wilfried Bauer , David Bodmer , Christian Bruns , Ivo Felner , Heribert Hellstern , Ian Lewis , Mark Meisenbach , Gisbert Weckbecker , Bernhard Wietfeld
IPC分类号: C07K7/64
CPC分类号: C07K7/64 , A61K38/00 , C07K14/655 , Y02P20/55
摘要: The invention provides cyclo[{4-(NH2—C2H4—NH—CO—O—)Pro}-Phg-DTrp-Lys-Tyr(4-Benzyl)-Phe], optionally in protected form, or a pharmaceutically acceptable salt or complex thereof, which has interesting pharmaceutical properties.
摘要翻译: 本发明提供任选以保护形式的环[{4-(NH 2 -C 2 H 4 -NH-CO-O-)Pro} -Phg-DTrp-Lys-Tyr(4-苄基)-Phe]或其药学上可接受的盐或 其复合物,其具有有趣的药物性质。
-
公开(公告)号:US20110166320A1
公开(公告)日:2011-07-07
申请号:US13048935
申请日:2011-03-16
申请人: Rainer Albert , Wilfried Bauer , David Bodmer , Christian Bruns , Ivo Felner , Heribert Hellstern , Ian Lewis , Mark Meisenbach , Gisbert Weckbecker , Bernhard Wietfeld
发明人: Rainer Albert , Wilfried Bauer , David Bodmer , Christian Bruns , Ivo Felner , Heribert Hellstern , Ian Lewis , Mark Meisenbach , Gisbert Weckbecker , Bernhard Wietfeld
IPC分类号: C07K7/64
CPC分类号: C07K7/64 , A61K38/00 , C07K14/655 , Y02P20/55
摘要: The invention provides cyclo[{4-(NH2—C2H4—NH—CO—O—)Pro}-Phg-DTrp-Lys-Tyr(4-Benzyl)-Phe], optionally in protected form, or a pharmaceutically acceptable salt or complex thereof, which has interesting pharmaceutical properties.
-
公开(公告)号:US20150218223A1
公开(公告)日:2015-08-06
申请号:US14681226
申请日:2015-04-08
申请人: Rainer Albert , Wilfried Bauer , David Bodmer , Christian Bruns , Ivo Felner , Heribert Hellstern , Ian Lewis , Mark Meisenbach , Gisbert Weckbecker , Bernhard Wietfeld
发明人: Rainer Albert , Wilfried Bauer , David Bodmer , Christian Bruns , Ivo Felner , Heribert Hellstern , Ian Lewis , Mark Meisenbach , Gisbert Weckbecker , Bernhard Wietfeld
IPC分类号: C07K7/64
CPC分类号: C07K7/64 , A61K38/00 , C07K14/655 , Y02P20/55
摘要: The invention provides cyclo[{4-(NH2—C2H4—NH—CO—O—)Pro}-Phg-DTrp-Lys-Tyr(4-Benzyl)-Phe], optionally in protected form, or a pharmaceutically acceptable salt or complex thereof, which has interesting pharmaceutical properties.
摘要翻译: 本发明提供任选以保护形式的环[{4-(NH 2 -C 2 H 4 -NH-CO-O-)Pro} -Phg-DTrp-Lys-Tyr(4-苄基)-Phe]或其药学上可接受的盐或 其复合物,其具有有趣的药物性质。
-
公开(公告)号:US20110172157A1
公开(公告)日:2011-07-14
申请号:US13048932
申请日:2011-03-16
申请人: Rainer Albert , Wilfried Bauer , David Bodmer , Christian Bruns , Ivo Felner , Heribert Hellstern , Ian Lewis , Mark Meisenbach , Gisbert Weckbecker , Bernhard Wietfeld
发明人: Rainer Albert , Wilfried Bauer , David Bodmer , Christian Bruns , Ivo Felner , Heribert Hellstern , Ian Lewis , Mark Meisenbach , Gisbert Weckbecker , Bernhard Wietfeld
CPC分类号: C07K7/64 , A61K38/00 , C07K14/655 , Y02P20/55
摘要: The invention provides cyclo[{4-(NH2—C2H4—NH—CO—O—)Pro}-Phg-DTrp-Lys-Tyr(4-Benzyl)-Phe], optionally in protected form, or a pharmaceutically acceptable salt or complex thereof, which has interesting pharmaceutical properties.
摘要翻译: 本发明提供任选以保护形式的环[{4-(NH 2 -C 2 H 4 -NH-CO-O-)Pro} -Phg-DTrp-Lys-Tyr(4-苄基)-Phe]或其药学上可接受的盐或 其复合物,其具有有趣的药物性质。
-
公开(公告)号:US07473761B2
公开(公告)日:2009-01-06
申请号:US10343288
申请日:2001-07-30
申请人: Rainer Albert , Wilfried Bauer , David Bodmer , Christian Bruns , Ivo Felner , Heribert Hellstern , Ian Lewis , Mark Meisenbach , Gisbert Weckbecker , Bernhard Wietfeld
发明人: Rainer Albert , Wilfried Bauer , David Bodmer , Christian Bruns , Ivo Felner , Heribert Hellstern , Ian Lewis , Mark Meisenbach , Gisbert Weckbecker , Bernhard Wietfeld
IPC分类号: C07K7/64
CPC分类号: C07K7/64 , A61K38/00 , C07K14/655 , Y02P20/55
摘要: The invention provides cyclo[{4-(NH2—C2H4—NH—CO—O—)Pro}-Phg-DTrp-Lys-Tyr(4-Benzyl)-Phe], optionally in protected form, or a pharmaceutically acceptable salt or complex thereof, which has interesting pharmaceutical properties.
摘要翻译: 本发明提供任选以保护形式的环[{4-(NH 2 -C 2 H 4 -NH-CO-O-)Pro} -Phg-DTrp-Lys-Tyr(4-苄基)-Phe]或其药学上可接受的盐或 其复合物,其具有有趣的药物性质。
-
公开(公告)号:US09035021B2
公开(公告)日:2015-05-19
申请号:US13048935
申请日:2011-03-16
申请人: Rainer Albert , Wilfried Bauer , David Bodmer , Christian Bruns , Ivo Felner , Heribert Hellstern , Ian Lewis , Mark Meisenbach , Gisbert Weckbecker , Bernhard Wietfeld
发明人: Rainer Albert , Wilfried Bauer , David Bodmer , Christian Bruns , Ivo Felner , Heribert Hellstern , Ian Lewis , Mark Meisenbach , Gisbert Weckbecker , Bernhard Wietfeld
IPC分类号: C07K7/64 , C07K14/655 , A61K38/00
CPC分类号: C07K7/64 , A61K38/00 , C07K14/655 , Y02P20/55
摘要: The invention provides cyclo[{4-(NH2—C2H4—NH—CO—O—)Pro}-Phg-DTrp-Lys-Tyr(4-Benzyl)-Phe], optionally in protected form, or a pharmaceutically acceptable salt or complex thereof, which has interesting pharmaceutical properties.
摘要翻译: 本发明提供任选以保护形式的环[{4-(NH 2 -C 2 H 4 -NH-CO-O-)Pro} -Phg-DTrp-Lys-Tyr(4-苄基)-Phe]或其药学上可接受的盐或 其复合物,其具有有趣的药物性质。
-
公开(公告)号:US08822637B2
公开(公告)日:2014-09-02
申请号:US13048932
申请日:2011-03-16
申请人: Rainer Albert , Wilfried Bauer , David Bodmer , Christian Bruns , Ivo Felner , Heribert Hellstern , Ian Lewis , Mark Meisenbach , Gisbert Weckbecker , Bernhard Wietfeld
发明人: Rainer Albert , Wilfried Bauer , David Bodmer , Christian Bruns , Ivo Felner , Heribert Hellstern , Ian Lewis , Mark Meisenbach , Gisbert Weckbecker , Bernhard Wietfeld
IPC分类号: C07K7/64
CPC分类号: C07K7/64 , A61K38/00 , C07K14/655 , Y02P20/55
摘要: The invention provides cyclo[{4-(NH2—C2H4—NH—CO—O-)Pro}-Phg-DTrp-Lys-Tyr(4-Benzyl)-Phe], optionally in protected form, or a pharmaceutically acceptable salt or complex thereof, which has interesting pharmaceutical properties.
摘要翻译: 本发明提供任选以保护形式的环[{4-(NH 2 -C 2 H 4 -NH-CO-O-)Pro} -Phg-DTrp-Lys-Tyr(4-苄基)-Phe]或其药学上可接受的盐或 其复合物,其具有有趣的药物性质。
-
公开(公告)号:US20090069225A1
公开(公告)日:2009-03-12
申请号:US12265135
申请日:2008-11-05
申请人: Rainer Albert , Wilfried Bauer , David Bodmer , Christian Bruns , Ivo Felner , Heribert Hellstern , Ian Lewis , Mark Meisenbach , Gisbert Weckbecker , Bernhard Wietfeld
发明人: Rainer Albert , Wilfried Bauer , David Bodmer , Christian Bruns , Ivo Felner , Heribert Hellstern , Ian Lewis , Mark Meisenbach , Gisbert Weckbecker , Bernhard Wietfeld
CPC分类号: C07K7/64 , A61K38/00 , C07K14/655 , Y02P20/55
摘要: The invention provides cyclo[{4-(NH2—C2H4—NH—CO—O—)Pro}-Phg-DTrp-Lys-Tyr(4-Benzyl)-Phe], optionally in protected form, or a pharmaceutically acceptable salt or complex thereof, which has interesting pharmaceutical properties.
摘要翻译: 本发明提供任选以保护形式的环[{4-(NH 2 -C 2 H 4 -NH-CO-O-)Pro} -Phg-DTrp-Lys-Tyr(4-苄基)-Phe]或其药学上可接受的盐或 其复合物,其具有有趣的药物性质。
-
公开(公告)号:US06225284B1
公开(公告)日:2001-05-01
申请号:US08981426
申请日:1997-12-29
申请人: Rainer Albert , Wilfried Bauer , Christian Bruns , Nagarajan Chandramouli , Ian Lewis , Gisbert Weckbecker
发明人: Rainer Albert , Wilfried Bauer , Christian Bruns , Nagarajan Chandramouli , Ian Lewis , Gisbert Weckbecker
IPC分类号: A61K3808
CPC分类号: C07K14/6555 , A61K38/00 , A61K51/083 , A61K51/088
摘要: Somatostain analogues comprising the amino acid sequence of the formula (I): -(D/L)Trp-Lys-X1-X2, wherein X1 is a substituted Thr, Ser, Tyr, Glu or Cys residue and X2 is an &agr;-amino acid having an aromatic residue on the C&agr; side chain, or an amino acid unit selected from Dab, Dpr, Dpm, His (Bzl)HyPro, thienyl-Ala, cyclohexyl-Ala and t.-butyl-Ala, the residue Lys of said sequence corresponding to the residue Lys9 of the native somatostatin-14, in free form, in salt form or complexed with a detectable element have interesting pharmacological properties.
摘要翻译: 包含式(I)的氨基酸序列的生长抑素类似物: - (D / L)Trp-Lys-X1-X2,其中X1是取代的Thr,Ser,Tyr,Glu或Cys残基,X2是α-氨基 在Calpha侧链上具有芳香残基的酸或选自Dab,Dpr,Dpm,His(Bzl)HyPro,噻吩基-Ala,环己基-Ala和叔丁基-AlA的氨基酸单元,所述 对应于天然生长抑素-14的游离形式的残基Lys9以盐形式或与可检测元件复合的序列具有有趣的药理学性质。
-
-
-
-
-
-
-
-
-